Find verified Acalabrutinib dihydrate API manufacturers, suppliers, and distributors across the globe. Explore companies that offer high-purity Acalabrutinib dihydrate for pharmaceutical use, along with product details, certifications, and reliable sourcing options. Compare prices, check availability, and connect directly with trusted suppliers for Acalabrutinib dihydrate API.
Alternate Names: UNII-F86EN73XQR, F86EN73XQR
CAS No: 2648852-74-6
PubChem CID: 156749065
Mol Formula: C26H27N7O4
Mol Weight: 501.5 g/mol
IUPAC Name: 4-[8-amino-3-[(2S)-1-but-2-ynoylpyrrolidin-2-yl]imidazo[1,5-a]pyrazin-1-yl]-N-pyridin-2-ylbenzamide;dihydrate
API Description: Acalabrutinib dihydrate is a selective Bruton's tyrosine kinase (BTK) inhibitor used in cancer therapy. It is primarily indicated for treating chronic lymphocytic leukemia (CLL) and small lymphocytic lymphoma (SLL). It is also used for mantle cell lymphoma (MCL) in patients who have received at least one prior therapy.
